These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6809710)

  • 21. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen.
    Bruckner HW; Cohen CJ; Feuer E; Holland JF
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):349-56. PubMed ID: 2492648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy for advanced ovarian cancer: a prospective randomized trial comparing hexamethylmelamine and cyclophosphamide to doxorubicin and cyclophosphamide.
    Schwartz PE; Lawrence R; Katz M
    Cancer Treat Rep; 1981; 65(1-2):137-41. PubMed ID: 6261948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early diagnosis and effective treatment of ovarian cancer].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of hyperthermia and chemotherapy in animals.
    Marmor JB
    Cancer Res; 1979 Jun; 39(6 Pt 2):2269-76. PubMed ID: 87264
    [No Abstract]   [Full Text] [Related]  

  • 25. Hexamethylmelamine, doxorubicin, and cyclophosphamide in advanced ovarian cancer resistant to previous chemotherapy.
    Sessa C; Bolis G; Valente I; Mangioni C; D'Incalci M
    Cancer Treat Rep; 1981; 65(1-2):172-3. PubMed ID: 6784922
    [No Abstract]   [Full Text] [Related]  

  • 26. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
    Levin L; Hryniuk W
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active specific immunotherapy in ovarian cancer.
    Crowther ME; Levin L; Poulton TA; Saffrey MJ; Curling OM; Hudson CN
    Recent Results Cancer Res; 1978; 68():166-73. PubMed ID: 752855
    [No Abstract]   [Full Text] [Related]  

  • 28. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
    Pater JL; Carmichael JA; Krepart GV; Fraser RC; Roy M; Kirk ME; Levitt M; Brown LB; Wilson KS; Shelley WE
    Cancer Treat Rep; 1987 Mar; 71(3):277-81. PubMed ID: 3102056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
    de Gramont A; Drolet Y; Louvet C; Dray C; Krulik M; Pigné A; Lavoie A; Painchaud M; Blouin R; Tessier C
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(1):105-9. PubMed ID: 3084619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy.
    Hainsworth JD; Malcolm A; Johnson DH; Burnett LS; Jones HW; Greco FA
    Obstet Gynecol; 1983 May; 61(5):619-23. PubMed ID: 6403897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of advanced ovarian cancer].
    de Gramont A; Krulik M; Pigne A; Brissaud P; Sirinelli A; Hubert D; Zylberait D; Debray J
    Sem Hop; 1984 Mar; 60(14):957-60. PubMed ID: 6326283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of ovarian cancer: past and present.
    Young RC
    Semin Oncol; 1975 Sep; 2(3):267-76. PubMed ID: 827024
    [No Abstract]   [Full Text] [Related]  

  • 35. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disseminated breast cancer. Current responses to cytotoxic drugs.
    Sannan HJ; Ruby W; Garb S; Bograd M; Levine S
    Rocky Mt Med J; 1978; 75(5):247-54. PubMed ID: 694337
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
    Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
    Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [High-dose chemotherapy in ovarian adenocarcinoma].
    Lotz JP; Lhommé C; Pautier P; Couteau C; Gligorov J; Alexandre J; Selle F; Izrael V; Maraninchi D; Viens P
    Bull Cancer; 2000 Jan; 87(1):63-9. PubMed ID: 10673633
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy of epithelial ovarian carcinoma].
    Bruntsch U; Gallmeier WM
    MMW Munch Med Wochenschr; 1983 Nov; 125(44):993-5. PubMed ID: 6417517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.